<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - Sellas Life Sciences Group</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Sun, 26 Apr 2026 03:54:53 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>SLS - Sellas Life Sciences Group / On Buy Rating</title>
<link>http://www.aktiencheck.de/forum/SLS_Sellas_Life_Sciences_Group_On_Buy_Rating-A2PU3T-t572758</link>
<guid>http://www.aktiencheck.de/forum/SLS_Sellas_Life_Sciences_Group_On_Buy_Rating-A2PU3T-t572758</guid>
<description>time to fly,  [&lt;a href=&#034;http://www.aktiencheck.de/forum/SLS_Sellas_Life_Sciences_Group_On_Buy_Rating-A2PU3T-t572758&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>SELLAS Life Sciences Group (WKN: A2PU3T)</title>
<link>http://www.aktiencheck.de/forum/SELLAS_Life_Sciences_Group_WKN_A2PU3T-A2PU3T-t579527</link>
<guid>http://www.aktiencheck.de/forum/SELLAS_Life_Sciences_Group_WKN_A2PU3T-A2PU3T-t579527</guid>
<description>SELLAS Life Sciences-Aktie fällt, da die Studie,  zur akuten myeloischen Leukämie länger als erwartet stattfinden wird

https://finance.yahoo.com/news/sellas-life-sciences-shares-tumble-182518387. [&lt;a href=&#034;http://www.aktiencheck.de/forum/SELLAS_Life_Sciences_Group_WKN_A2PU3T-A2PU3T-t579527&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







